ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
8,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
14,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
15,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
18,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
20,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
20,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
23,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
24,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
25,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
25,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
25,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
25,6,Erythrasma,Corynebacteria infections,Bacterial infectious disorders,Infec,N
25,7,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
25,8,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
25,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,11,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,12,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
25,13,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
26,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
26,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
27,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
29,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
30,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
30,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
31,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
31,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
32,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
32,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,8,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
32,9,Headache,Headaches NEC,Headaches,Nerv,N
32,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
32,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,12,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,13,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
32,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
34,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
34,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
34,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
35,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
35,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
35,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
35,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
35,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
36,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
37,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
37,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
37,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
38,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
38,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
38,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Allergic cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
40,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
41,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
41,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
43,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
43,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
43,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
45,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
45,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
46,1,Migraine,Migraine headaches,Headaches,Nerv,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
49,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
50,2,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
50,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
51,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
53,2,Administration site warmth,Administration site reactions NEC,Administration site reactions,Genrl,N
53,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
54,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
54,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,7,Vaccination site pain,Vaccination site reactions,Administration site reactions,Genrl,N
55,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
55,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
56,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
56,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
58,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
59,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
60,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
62,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
62,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
62,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
63,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
64,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
65,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
66,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
67,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
67,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
67,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
70,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
70,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
70,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
72,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
73,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
74,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
74,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
74,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
75,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
75,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
76,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
77,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
78,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
80,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
81,1,Severe cutaneous adverse reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
82,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
83,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
83,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
84,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
85,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
